Biolase Patents Laser Tech for Eye Conditions
The US Patent and Trademark Office has issued dental laser manufacturer Biolase Inc. a patent covering the use of its laser technologies for treating eye conditions.
Patent No. 8,366,702, titled “Methods for Treating Hyperopia and Presbyopia via Laser Tunneling,” expands the laser application of previous ophthalmic patents granted to Biolase. It includes the architecture and techniques for treating ocular and related tissue sites using laser energy in conjunction with a measuring device capable of determining anatomical structure thickness. Treatment methods covered under the patent include those for the eye conditions presbyopia, glaucoma, retinal disorders and cataracts.
This is Biolase’s fourth US patent issued in this category, with three additional patents issued internationally.
For more information, visit:
www.biolase.com
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024